Verified Nov 2026
Other
·
Durham, North Carolina
·
Since 2012
Bioventus is a medical technology company headquartered in Durham, North Carolina, founded in 2012. It develops and commercializes products for active healing and orthobiologics aimed at musculoskeletal conditions, including pain treatments, restorative therapies, and surgical solutions. The company has an estimated 500 to 1,000 employees and revenue in the $500 million to $1 billion range. It is publicly traded on Nasdaq under the ticker BVS, having become independent in February 2021. It serves the medical, automotive, electric-vehicle, and industrial equipment sectors. Recent reporting includes its second quarter 2026 financial results.
Bioventus at a glance
Revenue
$500M-1B
Est. band
Employees
500-1,000
Founded
2012
Headquarters
Durham, North Carolina
Certifications
ISO 13485
Import activity
205
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
205
Named foreign suppliers
4
Top origins
Japan · Italy · Hong Kong S.A.R. · South Korea
Shared foreign counterparties do not establish that these companies buy from Bioventus.
What this tells a buyer
Bioventus disclosed a new $400 million senior secured credit agreement in August 2025, which the company said lowers interest expense and increases liquidity.
Its product areas include peripheral nerve stimulation devices, hyaluronic acid joint fluid therapies, bone healing systems, skin allografts, and bone graft substitutes, and it holds ISO 13485 certification.
Source: US customs bill-of-lading records and public filings · Last verified Nov 05, 2026
STABILITY SIGNALS
Established & active
14 years in operation (founded 2012).
Holds ISO 13485 certification(s) per public sources.
Overview
Bioventus is a medical technology company headquartered in Durham, North Carolina, founded in 2012. It develops and commercializes products for active healing and orthobiologics aimed at musculoskeletal conditions, including pain treatments, restorative therapies, and surgical solutions. The company has an estimated 500 to 1,000 employees and revenue in the $500 million to $1 billion range. It is publicly traded on Nasdaq under the ticker BVS, having become independent in February 2021. It serves the medical, automotive, electric-vehicle, and industrial equipment sectors. Recent reporting includes its second quarter 2026 financial results.
At a glance
Attribute | Detail |
|---|---|
Founded | 2012 |
Headquarters | Durham, North Carolina |
Employees | 500-1,000 |
Revenue | $500M-1B (estimated) |
Certifications | ISO 13485 |
What Bioventus makes
Its product areas include peripheral nerve stimulation devices, hyaluronic acid joint fluid therapies, bone healing systems, skin allografts, and bone graft substitutes, and it holds ISO 13485 certification.
Certifications
Bioventus is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 13485 — jobleads.com
Trade and customs footprint
Bioventus disclosed a new $400 million senior secured credit agreement in August 2025, which the company said lowers interest expense and increases liquidity. US customs bill-of-lading records list 205 inbound shipments across 4 foreign suppliers, with top origins including Japan · Italy · Hong Kong S.A.R. · South Korea.
Latest developments
2026-11-02 — Document (sec.gov)
2026-08-05 — Bioventus Reports Second Quarter Financial Results - Bioventus Inc (bioventus.com)
2026-03-05 — Bioventus Announces Fourth Quarter and Full Year 2025 Financial Results - Bioventus Inc (bioventus.com)
2026-01-14 — Bioventus (BVS) FY 2026 Earnings Call Transcript & Audio (stockanalysis.com)
2025-08-04 — Bioventus Enters into a New $400 Million Senior Secured Credit Agreement Lowering Interest Expense and Providing Increased Liquidity - Bioventus Inc (bioventus.com)
2025-07-30 — Bioventus Receives FDA 510(k) Clearances for two Next-Generation Peripheral Nerve Stimulation Products - Bioventus Inc (bioventus.com)
Facilities
Bioventus is headquartered in Durham, North Carolina. Public sources also reference these locations:
Durham, NC — bioventus.com
Memphis, TN — exogen.com
Company details
Bioventus was founded in 2012, has an estimated 500-1,000 employees, and is headquartered in Durham, North Carolina. On the LightSource stability read it is rated "Established & active": 14 years in operation (founded 2012). Holds ISO 13485 certification(s) per public sources.
Frequently asked questions
What does Bioventus do?
Bioventus is a medical technology company headquartered in Durham, North Carolina, founded in 2012. It develops and commercializes products for active healing and orthobiologics aimed at musculoskeletal conditions, including pain treatments, restorative therapies, and surgical solutions. The company has an estimated 500 to 1,000 employees and revenue in the $500 million to $1 billion range. It is publicly traded on Nasdaq under the ticker BVS, having become independent in February 2021. It serves the medical, automotive, electric-vehicle, and industrial equipment sectors. Recent reporting includes its second quarter 2026 financial results.
Where is Bioventus headquartered?
Bioventus is headquartered in Durham, North Carolina (4721 Emperor Boulevard, Durham, North Carolina, 27703).
When was Bioventus founded?
Bioventus was founded in 2012.
How big is Bioventus?
Bioventus has an estimated 500-1,000 employees, with revenue in the $500M-1B range (estimated).
What certifications does Bioventus hold?
Bioventus lists ISO 13485 on its website. Confirm the certified scope for the specific plant producing your part.
Does Bioventus import from overseas suppliers?
US customs bill-of-lading records show 205 inbound shipments for Bioventus, with top origins including Japan · Italy · Hong Kong S.A.R. · South Korea.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.